Get the Stockscreener App
80.08
39.85%
-53.06
After Hours:
80.41
0.33
+0.41%
Icon Plc stock is traded at $80.08, with a volume of 23.54M.
It is down -39.85% in the last 24 hours and down -55.55% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$133.14
Open:
$79.97
24h Volume:
23.54M
Relative Volume:
17.68
Market Cap:
$6.11B
Revenue:
$8.10B
Net Income/Loss:
$599.48M
P/E Ratio:
10.83
EPS:
7.3969
Net Cash Flow:
$971.50M
1W Performance:
-44.92%
1M Performance:
-55.55%
6M Performance:
-52.64%
1Y Performance:
-57.07%
1-Day Range:
$66.57
$87.00
1-Week Range:
$66.57
$155.00
52-Week Range:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
80.08 | 10.17B | 8.10B | 599.48M | 971.50M | 7.3969 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Truist | Buy → Hold |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
ICON Public Limited Company Under Investigation for Securities Law Violations - Intellectia AI
ICON plc (ICLR) Shares Crater Amid Delayed Financial - GlobeNewswire
U.S. Indexes Decreased Thursday; Icon PLC Posted Biggest Loss - Barron's
Icon PLC to delay results, says revenue may have been overstated in 2023 and 2024 - MSN
Ademi LLP Investigates Claims of Securities Fraud against ICON p - GuruFocus
Ademi LLP Investigates Claims of Securities Fraud against ICON plc - PR Newswire
ICON stock rating reiterated at Hold by TD Cowen amid accounting probe By Investing.com - Investing.com Nigeria
ICON stock rating reiterated at Hold by TD Cowen amid accounting probe - Investing.com UK
Shares in Icon Plc plunge 40% amid internal accounting investigation - Business Post
ICON stock sinks nearly 40% after accounting probe pulls guidance; what investors watch next - Bez Kabli
INVESTOR ALERT: Investigation of ICON plc (ICLR) by Holzer & Holzer, LLC - GlobeNewswire
ICON (ICLR) Shares Plummet Amid Accounting Probe - GuruFocus
Rosen Law Firm Encourages ICON plc Investors to Inquire About Securities Class Action Investigation – ICLR - The AI Journal
ICON stock price target lowered to $100 by BMO Capital on accounting probe By Investing.com - Investing.com Canada
Why this drug-research company’s stock had its worst day since 1999 - MarketWatch
ICON (ICLR) stock price tumbles 40% after accounting probe delays 2025 results - Bez Kabli
Icon (ICLR) Shares Plummet by 40% Amid Market Volatility - GuruFocus
Icon (ICLR) Faces Rating Suspension Amidst Accounting Investigat - GuruFocus
Icon (ICLR) Faces Downgrade Amid Ongoing Accounting Investigatio - GuruFocus
Leerink Partners downgrades ICON stock rating to Market Perform on accounting concerns - Investing.com UK
Leerink Partners downgrades ICON stock rating to Market Perform on accounting concerns By Investing.com - Investing.com Nigeria
ICON stock rating downgraded by BofA Securities amid accounting concerns By Investing.com - Investing.com South Africa
ICON Shares Slump Amid Internal Investigation - 富途牛牛
ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to - GlobeNewswire
ICON stock rating suspended by Evercore amid accounting investigation By Investing.com - Investing.com India
ICON Shares Plunge After Launching Accounting Probe - Bloomberg.com
The Clinical Crisis: A Deep-Dive Into ICON plc (ICLR) Amidst a Transformational Storm - FinancialContent
Icon PLC stock hits 52-week low at $79.49 - Investing.com
Medtech Plummets 30% On Profit-Threatening Investigation - Investor's Business Daily
ICLR Down 30%: ICON plc Investigated For Securities Fraud; Block & Leviton Encourages ... - Bluefield Daily Telegraph
ICLR Down 30%: ICON plc Investigated For Securities Fraud; - GlobeNewswire
Mitchell Capital Management Co. Acquires New Shares in Icon Plc $ICLR - MarketBeat
Icon Plc share plunge wipes out $5bn as Irish firm says revenue may have been overstated in 2023 and 2024 - The Irish Independent
Icon Plc to delay results, says revenue may have been overstated in 2023 and 2024 - The Irish Independent
ICLR to Postpone Earnings Amid Internal Accounting Investigation - GuruFocus
ICLR Announces Internal Probe into Accounting Practices - GuruFocus
Clinical Research Provider Icon Stock Crashes On Accounting Probe - Benzinga
S&P 500 Futures Climb in Premarket Trading; Icon PLC, Baxter International Lag - Barron's
ICON stock plummets after accounting investigation delays earnings By Investing.com - Investing.com UK
US Stock Movement | ICON PLC Drops Over 35% in Pre-market Trading - bitget.com
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices - Business Wire
Preliminary results of ICON plc's internal investigation indicate that the company's operating revenue for fiscal years 2023 and 2024 may have been slightly overstated. - bitget.com
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - Finviz
Icon (ICLR) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Icon Plc $ICLR Stock Position Lowered by Diamond Hill Capital Management Inc. - MarketBeat
State of Michigan Retirement System Raises Position in Icon Plc $ICLR - MarketBeat
Icon faces court claims from former staff over use of retirement assets in US - The Irish Independent
Is ICON (ICLR) Quietly Redefining Its Oncology Moat With the Brian Moran Institute Expansion? - simplywall.st
It's Down 28% But ICON Public Limited Company (NASDAQ:ICLR) Could Be Riskier Than It Looks - Sahm
Icon Plc (NASDAQ:ICLR) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Icon PLC (ICLR) Shares Down 6.3% on Feb 5 - GuruFocus
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):